Biblio Discovery — Demo Discovery Service

13 hasil untuk "Lin WU"

Menampilkan 1–13 · 0,33 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Case study on the first immigration of fall armyworm, Spodoptera frugiperda invading into China

    Xiaoxu Sun; Chaoxing Hu; Huiru Jia dkk.

    Journal of Integrative Agriculture · 2021 · Inggris · OpenAlex Scopus

    The fall armyworm (FAW), Spodoptera frugiperda is one of the most damaging crop pests, and it has become major threat to the food security of many countries. In order to monitor possible invasion of this pest into China, a searchlight trap was established in March 2018 in western Yunnan Province…

  2. Artikel Jurnal Teks lengkap

    Interfacial self-healing polymer electrolytes for long-cycle solid-state lithium-sulfur batteries

    Fei Pei; Lin Wu; Yi Zhang dkk.

    Nature Communications · 2024 · Inggris · OpenAlex Scopus

    Coupling high-capacity cathode and Li-anode with solid-state electrolyte has been demonstrated as an effective strategy for increasing the energy densities and safety of rechargeable batteries. However, the limited ion conductivity, the large interfacial resistance, and unconstrained Li-dendrite…

  3. Artikel Jurnal Teks lengkap

    The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

    Shun Wang; Yan Zheng; Feng Yang dkk.

    Signal Transduction and Targeted Therapy · 2021 · Inggris · OpenAlex Scopus

    Pancreatic cancer is an increasingly common cause of cancer mortality with a tight correspondence between disease mortality and incidence. Furthermore, it is usually diagnosed at an advanced stage with a very dismal prognosis. Due to the high heterogeneity, metabolic reprogramming, and dense…

  4. Artikel Jurnal Teks lengkap

    A 6-year-long (2013–2018) high-resolution air quality reanalysis dataset in China based on the assimilation of surface observations from CNEMC

    Lei Kong; Xiao Tang; Jiang Zhu dkk.

    Earth system science data · 2021 · Inggris · OpenAlex Scopus

    A 6-year-long high-resolution Chinese air quality reanalysis (CAQRA) dataset is presented in this study obtained from the assimilation of surface observations from the China National Environmental Monitoring Centre (CNEMC) using the ensemble Kalman filter (EnKF) and Nested Air Quality Prediction…

  5. Artikel Jurnal Teks lengkap

    Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

    Wen-Zhao Zhong; Qun Wang; Weimin Mao dkk.

    Journal of Clinical Oncology · 2020 · Inggris · OpenAlex Scopus

    PURPOSE ADJUVANT-CTONG1104 (ClinicalTrials.gov identifier: NCT01405079 ), a randomized phase III trial, showed that adjuvant gefitinib treatment significantly improved disease-free survival (DFS) versus vinorelbine plus cisplatin (VP) in patients with epidermal growth factor receptor ( EGFR)…

  6. Artikel Jurnal Teks lengkap

    Perioperative Nivolumab in Resectable Lung Cancer

    Tina Cascone; Mark Magdi Awad; Jonathan David Spicer dkk.

    New England Journal of Medicine · 2024 · Inggris · OpenAlex Scopus

    BACKGROUND: Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non-small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadjuvant therapy followed by surgery and adjuvant therapy) with nivolumab may further improve…

  7. Artikel Jurnal Teks lengkap

    Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy

    Jumin Huang; Di Liu; Yuwei Wang dkk.

    Gut · 2021 · Inggris · OpenAlex Scopus

    Objective Programmed death 1 and its ligand 1 (PD-1/PD-L1) immunotherapy is promising for late-stage lung cancer treatment, however, the response rate needs to be improved. Gut microbiota plays a crucial role in immunotherapy sensitisation and Panax ginseng has been shown to possess…

  8. Artikel Jurnal

    Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

    Ying Cheng; Liang Han; Lin Wu dkk.

    JAMA · 2022 · Inggris · OpenAlex

    Importance: Programmed cell death ligand 1 inhibitors combined with chemotherapy has changed the approach to first-line treatment in patients with extensive-stage small cell lung cancer (SCLC). It remained unknown whether adding a programmed cell death 1 (PD-1) inhibitor to chemotherapy provided…

  9. Artikel Jurnal

    Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer

    Shun Lü; Wei Dong Zhang; Lin Wu dkk.

    JAMA · 2024 · Inggris · OpenAlex

    Importance: Adjuvant and neoadjuvant immunotherapy have improved clinical outcomes for patients with early-stage non-small cell lung cancer (NSCLC). However, the optimal combination of checkpoint inhibition with chemotherapy remains unknown. Objective: To determine whether toripalimab in…

  10. Artikel Jurnal Teks lengkap

    Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Hui Luo; Jin Lü; Yuxian Bai dkk.

    JAMA · 2021 · Inggris · OpenAlex

    Importance: Standard first-line therapy for advanced or metastatic esophageal carcinoma is chemotherapy, but the prognosis remains poor. Camrelizumab (an anti-programmed death receptor 1 [PD-1] antibody) showed antitumor activity in previously treated advanced or metastatic esophageal squamous cell…

  11. Artikel Jurnal Teks lengkap

    Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

    Zixian Wang; Chengxu Cui; Jun Yao dkk.

    Cancer Cell · 2022 · Inggris · OpenAlex Scopus

    Platinum-based chemotherapy is the standard first-line treatment for advanced esophageal squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial.gov: NCT03829969), 514 patients with treatment-naïve advanced ESCC were randomized (1:1) to receive toripalimab or placebo in combination…